TSO for Plaque Psoriasis
NCT02011269 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-05-06
Summary
This is a randomized, blinded, multicenter study to assess the safety and treatment effect of 12 weeks of Trichuris suis ova in subjects diagnosed with moderate to severe chronic plaque psoriasis.
Conditions
Interventions
- BIOLOGICAL
-
Trichuris Suis Ova
Sponsors & Collaborators
-
Coronado Biosciences, Inc.
lead INDUSTRY
Principal Investigators
-
Michael Ryan · Coronado Biosciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2015-01-31
More Related Trials
-
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
NCT06643260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
NCT00050648 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis
NCT02601469 ·Status: COMPLETED ·Phase: PHASE2
-
AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis
NCT01300052 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00678210 ·Status: COMPLETED ·Phase: PHASE2
-
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01309737 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis
NCT01206660 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
NCT00617994 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
NCT05896527 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris
NCT01268527 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
NCT02949388 ·Status: COMPLETED ·Phase: PHASE2
-
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression
NCT02932878 ·Status: COMPLETED ·Phase: PHASE2
-
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
NCT00769184 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
NCT02494479 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis
NCT02932462 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
NCT03004339 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis
NCT01206387 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02635204 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris
NCT05254249 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis
NCT01029405 ·Status: COMPLETED ·Phase: PHASE2
-
Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis
NCT01279629 ·Status: SUSPENDED
-
Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
NCT05268016 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis
NCT00004468 ·Status: WITHDRAWN ·Phase: NA